microRNA与生物医学文献清单

不久前，2024年诺贝尔生理学或医学奖授予了科学家Victor Ambros和Gary Ruvkun，表彰他们发现微小RNA (microRNA)及其在转录后基因调控中的作用。您还在为筛选microRNA文献发愁吗？Biomedicines 期刊这份“microRNA与生物医学”方向的文献清单，定能为你提供灵感！

1.中性粒细胞在骨关节炎病理生理和治疗中的作用

The Involvement of Neutrophils in the Pathophysiology and Treatment of Osteoarthritis

https://www.mdpi.com/2227-9059/10/7/1604

2.使用心血管疾病相关的MicroRNA生物标志物对无先兆子痫的胎儿生长受限和小于胎龄儿进行孕早期筛查

First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers

https://www.mdpi.com/2227-9059/10/3/718

3.miRNA在多囊卵巢综合征中的转化作用：从实验室到临床——系统文献综述

The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review

https://www.mdpi.com/2227-9059/10/8/1816

4.生物标志物作为抗VEGF反应的预测因素

Biomarkers as Predictive Factors of Anti-VEGF Response

https://www.mdpi.com/2227-9059/10/5/1003

5.非编码RNA在胶质瘤中的作用

The Role of Non-Coding RNAs in Glioma

https://www.mdpi.com/2227-9059/10/8/2031

6.乳腺癌亚型特异性miRNA：网络、影响和干预潜力

Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention

https://www.mdpi.com/2227-9059/10/3/651

7.妊娠前期患有慢性高血压的女性和随后患上妊娠高血压或先兆子痫 (伴或不伴胎儿生长受限) 的正常血压女性中心血管疾病相关的MicroRNA失调

Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction

https://www.mdpi.com/2227-9059/10/2/256

8.miR-29s在人类癌症中的作用—最新进展

The Role of miR-29s in Human Cancers—An Update

https://www.mdpi.com/2227-9059/10/9/2121

9.小核仁衍生的RNA作为人类癌症的调节剂

Small Nucleolar Derived RNAs as Regulators of Human Cancer

https://www.mdpi.com/2227-9059/10/8/1819

10.细胞外囊泡的特征及临床应用前的临床前测试注意事项

Characteristics of Extracellular Vesicles and Preclinical Testing Considerations Prior to Clinical Applications

https://www.mdpi.com/2227-9059/10/4/869

11.MicroRNA：肝脏缺血再灌注损伤的新靶点

MicroRNAs: Novel Targets in Hepatic Ischemia–Reperfusion Injury

https://www.mdpi.com/2227-9059/10/4/791

12.外泌体MicroRNA作为组织工程和再生医学中的新型无细胞疗法

Exosomal MicroRNAs as Novel Cell-Free Therapeutics in Tissue Engineering and Regenerative Medicine

https://www.mdpi.com/2227-9059/10/10/2485

13.用于癌症检测的循环生物标志物：唾液microRNA可以成为卵巢癌诊断的机会吗？

Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?

https://www.mdpi.com/2227-9059/11/3/652

14.细胞外囊泡、细胞穿透肽和miRNA作为未来帕金森病和阿尔茨海默病的新型治疗干预手段

Extracellular Vesicles, Cell-Penetrating Peptides and miRNAs as Future Novel Therapeutic Interventions for Parkinson's and Alzheimer's Disease

https://www.mdpi.com/2227-9059/11/3/728

15.药物筛选显示盐酸米诺环素可作为预防乳腺癌细胞跨血脑屏障外渗的治疗选择

A Drug Screening Reveals Minocycline Hydrochloride as a Therapeutic Option to Prevent Breast Cancer Cells Extravasation across the Blood–Brain Barrier

https://www.mdpi.com/2227-9059/10/8/1988

Biomedicines 期刊介绍：https://www.mdpi.com/journal/biomedicines

主编： Prof. Dr. Felipe Fregni, Harvard Medical School, USA

期刊主题涵盖人类健康和疾病的所有方面，如疾病的发病机制、转化医学、纳米医学、临床研究、基因疗法、细胞疗法、靶向治疗、生物制品、生物医学研究中的生物材料、天然生物活性分子、疫苗、靶向特异性抗体、重组治疗蛋白、生物成像、生物传感器、生物标志物、生物仿制药和纳米生物仿制药等。目前期刊已被SCIE、Scopus和PubMed等数据库收录。

2023 Impact Factor：3.9  (Q1*)

2023 CiteScore：5.2

Time to First Decision：15.3

Acceptance to Publication：3.4

*Q1 (85/354) at category "Pharmacology & Pharmacy"